Home Pyridines 15264-63-8
15264-63-8,MFCD00215200
Catalog No.:AA007JAY

15264-63-8 | 5-(4-Pyridyl)-1,3,4-oxadiazole-2-thiol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$19.00   $14.00
- +
1g
98%(GC)
in stock  
$45.00   $32.00
- +
5g
95%
in stock  
$115.00   $81.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA007JAY
Chemical Name:
5-(4-Pyridyl)-1,3,4-oxadiazole-2-thiol
CAS Number:
15264-63-8
Molecular Formula:
C7H5N3OS
Molecular Weight:
179.1991
MDL Number:
MFCD00215200
SMILES:
Sc1nnc(o1)c1ccncc1
Properties
Computed Properties
 
Complexity:
223  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
1  

Downstream Synthesis Route

[1]Yoshida;Asai[YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1954,vol.74,p.951][Chem.Abstr.,1955,p.10938]

[1]Ahmad,Roshan;Iqbal,Rashid;Akhtar,Humaira;Duddeck,Helmut;Stefaniak,Lech;Sitkowski,Jerzy[Nucleosides,nucleotidesandnucleicacids,2001,vol.20,#9,p.1671-1682]

[2]CurrentPatentAssignee:REACTIONBIOLOGYCORP-WO2014/79545,2014,A1Locationinpatent:Page/Pagecolumn38

[3]Locationinpatent:experimentalpartGilani,SadafJamal;Khan,SuroorAhmad;Alam,Ozair;Siddiqui,Nadeem[Actapoloniaepharmaceutica,2011,vol.68,#2,p.205-211]

[4]Locationinpatent:experimentalpartLoMonte,Fabio;Kramer,Thomas;Gu,Jiamin;Anumala,UpendraRao;Marinelli,Luciana;LaPietra,Valeria;Novellino,Ettore;Franco,Bénédicte;Demedts,David;VanLeuven,Fred;Fuertes,Ana;Dominguez,JuanManuel;Plotkin,Batya;Eldar-Finkelman,Hagit;Schmidt,Boris[JournalofMedicinalChemistry,2012,vol.55,#9,p.4407-4424]

[5]LoMonte,Fabio;Kramer,Thomas;Gu,Jiamin;Brodrecht,Martin;Pilakowski,Johannes;Fuertes,Ana;Dominguez,JuanManuel;Plotkin,Batya;Eldar-Finkelman,Hagit;Schmidt,Boris[EuropeanJournalofMedicinalChemistry,2013,vol.61,p.26-40]

[6]Khan;Chawla,Gita;Mueed,M.Asad[IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2004,vol.43,#6,p.1302-1305]

[7]Yarmohammadi,Elahe;Beyzaei,Hamid;Aryan,Reza;Moradi,Ashraf[MolecularDiversity,2021,vol.25,#4,p.2367-2378]

[8]Lukas,ThomasJ.;Schiltz,GaryE.;Arrat,Hasan;Scheidt,Karl;Siddique,Teepu[BioorganicandMedicinalChemistryLetters,2014,vol.24,#6,p.1532-1537]

[9]CurrentPatentAssignee:NORTHWESTERNUNIVERSITY(ILLINOIS)-US2016/214969,2016,A1Locationinpatent:Paragraph0076-0077

[10]Sun,Guo-Xiang;Shi,Yan-Xia;Sun,Zhao-Hui;Yang,Ming-Yan;Wu,Hong-Ke;Weng,Jian-Quan;Tan,Cheng-Xia;Liu,Xing-Hai;Li,Bao-Ju;Zhang,Yong-Gang[Lettersindrugdesignanddiscovery,2014,vol.11,#9,p.1119-1123]

[11]Locationinpatent:experimentalpartGilani,SadafJ.;Khan,SuroorA.;Siddiqui,Nadeem[BioorganicandMedicinalChemistryLetters,2010,vol.20,#16,p.4762-4765]

[12]Locationinpatent:experimentalpartPatel,ManishkumarB.;Modi,NishithR.;Raval,JigneshP.;Menon,ShobhanaK.[OrganicandBiomolecularChemistry,2012,vol.10,#9,p.1785-1794]

[13]Locationinpatent:experimentalpartXia,Qingchun;Xu,Dongfang;He,Qizhuang;Li,Xingyu;Sun,Dazhi[ChineseJournalofChemistry,2010,vol.28,#12,p.2433-2440]

[14]Pflégr,Václav;Štěpánková,Šárka;Svrčková,Katarína;Švarcová,Markéta;Vinšová,Jarmila;Krátký,Martin[Pharmaceuticals,2022,vol.15,#4]

[15]Caneschi,Wiliam;Enes,KarineBraga;CarvalhodeMendonça,Camille;deSouzaFernandes,Fábio;Miguel,FabioBalbino;daSilvaMartins,Jefferson;LeHyaric,Mireille;Pinho,RobertoRosas;Duarte,LucasMattos;LealdeOliveira,MarconeAugusto;DosSantos,HélioF.;PazLopes,MiriamTeresa;Dittz,Dalton;Silva,Heveline;CostaCouri,MaraRubia[EuropeanJournalofMedicinalChemistry,2019,vol.165,p.18-30]

[16]Locationinpatent:experimentalpartRao,M.E.Bhanoji;Rajurkar,VikasG.[AsianJournalofChemistry,2011,vol.23,#6,p.2648-2652]

[17]Karabanovich,Galina;Zemanová,Júlia;Smutný,Tomáš;Székely,Rita;Šarkan,Michal;Centárová,Ivana;Vocat,Anthony;Pávková,Ivona;Čonka,Patrik;Němeček,Jan;Stolaříková,Jiřina;Vejsová,Marcela;Vávrová,Kateřina;Klimešová,Věra;Hrabálek,Alexandr;Pávek,Petr;Cole,StewartT.;Mikušová,Katarína;Roh,Jaroslav[JournalofMedicinalChemistry,2016,vol.59,#6,p.2362-2380]

[18]Kummari,LalithK.;Butler,MarkS.;Furlong,Emily;Blundell,Ross;Nouwens,Amanda;Silva,AlbertoB.;Kappler,Ulrike;Fraser,JamesA.;Kobe,Bostjan;Cooper,MatthewA.;Robertson,AvrilA.B.[BioorganicandMedicinalChemistry,2018,vol.26,#20,p.5408-5419]

[19]Pancechowsak-Ksepko;Foks;Janowiec;Zwolska-Kwiek[Actapoloniaepharmaceutica,1993,vol.50,#2-3,p.259-267]

[20]Dodd,DharmpalS.;Shen,Zhongqi;Nishi,Takao;Graber,Norma;Bealls,Dawson;Fong,Miranda;Ebert,Tracy[BioorganicandMedicinalChemistryLetters,1996,vol.6,#22,p.2693-2698]Chao,Shu-Jun;Hui,Xin-Ping;Li,Shuo;Qiu,Zao-Zao;Xu,Peng-Fei;Zhang,Zi-Yi;Wang,Qin;Guan,Zuo-Wu[JournaloftheChineseChemicalSociety,2005,vol.52,#3,p.539-544]

[21]Foks,Henryk;Czarnocka-Janowicz,Anna;Rudnicka,Waleria;Trzeciak,Henryk[Phosphorus,SulfurandSiliconandtheRelatedElements,2000,vol.164,p.67-81]

[22]Locationinpatent:schemeortableBayrak,Hacer;Demirbas,Ahmet;Demirbas,Neslihan;Karaoglu,SenguelAlpay[EuropeanJournalofMedicinalChemistry,2009,vol.44,#11,p.4362-4366]

[23]Locationinpatent:experimentalpartLiu,Kai;Lu,Xiang;Zhang,Hong-Jia;Sun,Juan;Zhu,Hai-Liang[EuropeanJournalofMedicinalChemistry,2012,vol.47,#1,p.473-478]

[24]Locationinpatent:schemeortableZhang,Li-Rong;Liu,Zhi-Jun;Zhang,Hui;Sun,Jian;Luo,Yin;Zhao,Ting-Ting;Gong,Hai-Bin;Zhu,Hai-Liang[BioorganicandMedicinalChemistry,2012,vol.20,#11,p.3615-3621]

[25]Locationinpatent:bodytextMohammedIqbal;Khan,AshrafY.;Kalashetti,MallikarjunB.;Belavagi,NingaraddiS.;Gong,Young-Dae;Khazi,ImitiyazAhmedM.[EuropeanJournalofMedicinalChemistry,2012,vol.53,p.308-315]

[26]Locationinpatent:experimentalpartYan,Xu;Zhou,Shuo;Wang,Yuanqiang;Ge,Zemei;Cheng,Tieming;Li,Runtao[Tetrahedron,2012,vol.68,#38,p.7978-7983]

[27]Du,Qian-Ru;Li,Dong-Dong;Pi,Ya-Zhou;Li,Jing-Ran;Sun,Jian;Fang,Fei;Zhong,Wei-Qing;Gong,Hai-Bin;Zhu,Hai-Liang[BioorganicandMedicinalChemistry,2013,vol.21,#8,p.2286-2297]

[28]Li,Zai-Shun;Wang,Wei-Min;Lu,Wei;Niu,Cong-Wei;Li,Yong-Hong;Li,Zheng-Ming;Wang,Jian-Guo[BioorganicandMedicinalChemistryLetters,2013,vol.23,#13,p.3723-3727]

[29]Zhang,Fei;Wang,Xiao-Liang;Shi,Jing;Wang,She-Feng;Yin,Yong;Yang,Yu-Shun;Zhang,Wei-Ming;Zhu,Hai-Liang[BioorganicandMedicinalChemistry,2014,vol.22,#1,p.468-477]

[30]Modh,RahulP;Shah,Dhruvin;Chikhalia,KishorH[IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2013,vol.52,#10,p.1318-1324]

[31]Ledeţi,Ionuţ;Bercean,Vasile;Alexa,Anda;Şoica,Codruţa;Şuta,Lenuţa-Maria;Dehelean,Cristina;Trandafirescu,Cristina;Muntean,Delia;Licker,Monica;Fuliaş,Adriana[JournalofChemistry,2015,vol.2015]

[32]Khalil,NadiaAbdalla;Kamal,AliaaMoh;Emam,SohaHussein[BiologicalandPharmaceuticalBulletin,2015,vol.38,#5,p.763-773]Havasi,MiaH.;Ressler,AndrewJ.;Parks,EdenL.;Cocolas,AlexanderH.;Weaver,Ashton;Seeram,NavindraP.;Henry,GeneiveE.[InorganicaChimicaActa,2020,vol.505]

[33]Shen;Wang;Sun;Wu;Tan;Weng;Liu[JournalofStructuralChemistry,2018,vol.59,#5,p.1236-1240][Zh.Strukt.Kim.,2018,vol.59,#5,p.1275-1279,5]

[34]Sabale,PrafullaM.;Mehta,Pooja[IndianJournalofHeterocyclicChemistry,2013,vol.23,#2,p.149-154]

[35]Tian,Kun;Li,Xiao-Qin;Zhang,Li;Gan,Yi-Yuan;Meng,Jiao;Wu,Shou-Qun;Wan,Jin-Lin;Xu,Yang;Cai,Chao-Ting;Ouyang,Gui-Ping;Wang,Zhen-Chao[ChemicalPapers,2019,vol.73,#1,p.17-25]

[36]Chavan,AbhijitP.;Deshpande,RujutaR.;Borade,NandkumarA.;Shinde,Abhijit;Mhaske,PravinC.;Sarkar,Dhiman;Bobade,VivekD.[MedicinalChemistryResearch,2019,vol.28,#11,p.1873-1884]

[37]El-Zahabi,MohamedAyman;Sakr,Helmy;El-Adl,Khaled.;Zayed,Mohamed;Abdelraheem,AdelS.;Eissa,SallyI.;Elkady,Hazem;Eissa,IbrahimH.[BioorganicChemistry,2020,vol.104]

[38]Liu,Jie;Zhang,Guang-Yu;Zhang,Zhe;Li,Bo;Chai,Fei;Wang,Qi;Zhou,Zi-Dan;Xu,Ling-Ling;Wang,Shou-Kai;Jin,Zhen;Tang,You-Zhi[BioorganicChemistry,2021,vol.112]

[39]Asif,Mohammad;Kamal,Mehnaz[IndianJournalofHeterocyclicChemistry,2021,vol.31,#1,p.45-50]

[40]Cheng,Wanqing;Fan,Jiangping;Guo,Yong;Han,Meiyue;Ma,Nannan;Yan,Xiaoting;Yang,Ruige[JournalofAgriculturalandFoodChemistry,2021,vol.69,#51,p.15544-15553]

[1]EuropeanJournalofMedicinalChemistry,1986,vol.21,p.267-269

[1]EuropeanJournalofMedicinalChemistry,1986,vol.21,p.267-269

[1]Locationinpatent:experimentalpartZhang,Li-Rong;Liu,Zhi-Jun;Zhang,Hui;Sun,Jian;Luo,Yin;Zhao,Ting-Ting;Gong,Hai-Bin;Zhu,Hai-Liang[BioorganicandMedicinalChemistry,2012,vol.20,#11,p.3615-3621]

[2]Sasaki,Tadashi;Ito,Eikoh;Shimizu,Ikuo[JournalofOrganicChemistry,1982,vol.47,#14,p.2757-2760]

[3]Khan;Chawla,Gita;Mueed,M.Asad[IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2004,vol.43,#6,p.1302-1305]

Literature

Title: Synthesis, characterization and antiamoebic activity of some hydrazone and azole derivatives bearing pyridyl moiety as a promising heterocyclic scaffold.

Journal: European journal of medicinal chemistry 20120301

Title: Tetra-aqua-bis-(2-{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfan-yl}acetato)-iron(II).

Journal: Acta crystallographica. Section E, Structure reports online 20111001

Title: 1,4-Bis{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfan-yl}butane.

Journal: Acta crystallographica. Section E, Structure reports online 20110301

Title: Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazid.

Journal: Bioorganic & medicinal chemistry letters 20100815

Title: New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site.

Journal: Bioorganic & medicinal chemistry 20100601

Title: 1,3,4-Oxadiazole-2(3H)-thione and its analogues: a new class of non-competitive nucleotide pyrophosphatases/phosphodiesterases 1 inhibitors.

Journal: Bioorganic & medicinal chemistry 20091115

Title: Synthesis of some new 1,2,4-triazoles starting from isonicotinic acid hydrazide and evaluation of their antimicrobial activities.

Journal: European journal of medicinal chemistry 20091101

Title: [Study on the spectroscopy of 5-(4-pyridyl)-1,3,4-oxadiazole-2-thiol].

Journal: Guang pu xue yu guang pu fen xi = Guang pu 20061201

Title: Modulated preparation and structural diversification of ZnII and CdII metal-organic frameworks with a versatile building block 5-(4-pyridyl)-1,3,4-oxadiazole-2-thiol.

Journal: Inorganic chemistry 20060724

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 15264-63-8
Tags:15264-63-8 Molecular Formula|15264-63-8 MDL|15264-63-8 SMILES|15264-63-8 5-(4-Pyridyl)-1,3,4-oxadiazole-2-thiol